This inventor holds 8 USPTO granted patents and 10 published patent applications. Top assignees: Kalivir Immunotherapeutics, Inc., Carnegie Mellon University, Kalivir Immunotherapeutcs, Inc.. Active years: 2015-2025.
Company Filing History:
6 out of 6 
1 out of 1,181 
1 out of 1 Years Active: 2015-2025
Title: Innovations of Mingrui Zhang in Oncolytic Immunotherapy
Introduction
Mingrui Zhang is a prominent inventor based in Pittsburgh, PA (US), known for his significant contributions to the field of oncolytic immunotherapy. With a total of 8 patents, Zhang has been at the forefront of developing innovative solutions aimed at enhancing cancer treatment through the use of modified oncolytic viruses.
Latest Patents
One of Zhang's latest patents is titled "Platform Oncolytic Vector for Systemic Delivery." This invention focuses on oncolytic immunotherapy by remodeling the tumor microenvironment. The disclosure relates to modified oncolytic viruses that include modifications in the viral genome encoding exogenous nucleic acids. These enhancements aim to improve the effectiveness of oncolytic immunotherapy by remodeling the tumor microenvironment and facilitating enhanced systemic delivery. Additionally, the patent covers compositions comprising the modified oncolytic viruses, kits containing these viruses, and methods for utilizing them in therapeutic applications.
Career Highlights
Throughout his career, Mingrui Zhang has worked with notable organizations such as Kalivir Immunotherapeutics, Inc. and Carnegie Mellon University. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in cancer therapies.
Collaborations
Zhang has collaborated with esteemed colleagues, including Stephen Howard Thorne and Daniel J Byrd. These partnerships have further enriched his research and development efforts in oncolytic immunotherapy.
Conclusion
Mingrui Zhang's innovative work in the field of oncolytic immunotherapy showcases his dedication to advancing cancer treatment through scientific research and invention. His contributions are paving the way for more effective therapies that could significantly impact patient outcomes.